QSimulate

QSimulateQSimulate
QSimulate

QSimulate

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

DR 552018ActiveBoston, United States
Rate

About

QSimulate develops quantum-powered simulation solutions that significantly reduce drug discovery timelines by applying advanced quantum mechanics to molecular simulations. Their platform, QUELO, is designed for peptide drug discovery and other complex molecular interactions, enabling faster and more accurate predictions.
Frequently asked

What does QSimulate do?

QSimulate develops quantum-powered simulation solutions that significantly reduce drug discovery timelines by applying advanced quantum mechanics to molecular simulations. Their platform, QUELO, is designed for peptide drug discovery and other complex molecular interactions, enabling faster and more accurate predictions.

What is QSimulate's revenue?

StartupHub estimates QSimulate's annual revenue at $1.0M (range $566K to $9.6M, 30% confidence), based on comparable companies in the sector.

What is QSimulate's valuation?

StartupHub estimates QSimulate's effective valuation at $53.6M (range $33.8M to $81.0M, 20% confidence), based on comparable companies in the sector.

How much funding has QSimulate raised?

QSimulate has raised a total of $14M in funding. The most recent round on record is Seed.

Where is QSimulate headquartered?

QSimulate is headquartered in Boston, United States.

When was QSimulate founded?

QSimulate was founded in 2018.

What industry does QSimulate operate in?

QSimulate operates in Drug Discovery, Biotech, Quantum Computing, Molecular Simulation, Computational Chemistry, AI Drug Discovery.

Comments

No comments yet. Be the first to share your take.